Information was received from a consumer and a manufacturing representative regarding a patient receiving intrathecal baclofen via an implantable infusion pump for intractable spasticity and cerebral palsy.The dose and concentration were unknown.It was reported that as of (b)(6) 2016, the patient had been sick for three days.However, when asked if the date was (b)(6) 2016, the reporter confirmed ¿yes, but he was venturing a guess¿.The patient complained of a stomach ache, and they thought it was the stomach virus.That seemed to get better, but then the patient had congestion.¿muscle convulsions¿ were noted.Every now and then, the patient ¿winced like in sharp pain¿.The patient was afraid the pump was failing.The patient was currently at home, and [their friend/family member] was hesitant to take the patient out and go to the hospital.The patient¿s pump was checked.There were no active alarms, and there was nothing in the pump logs that would suggest a pump issue.The representative explained to the consumer that there still could have been an issue with the rest of the system, but that the patient would need to be seen by his physician for the pump to look f urther into it.The patient¿s primary care physician was to see the patient on the evening of (b)(6) 2016.No interventions were mentioned.There were no further complications reported.
|